[grow_thumb image=”http://telecareaware.com/wp-content/uploads/2016/02/AAR-logo.jpg” thumb_width=”200″ /]The Accelerated Access Review (AAR)
aims to speed up access by NHS patients to innovative medicines, medtech and diagnostics, and digital health. Of these, digital health is the newest, and because it enables care to be delivered in a far more efficient and patient-centric way, offers great hope for the future of improved patient outcomes and controlled costs.
As someone outside government who was drawn into the digital health stream of the AAR, this blog aims to capture key learnings from the experience.
The initial list of obstacles to innovation in the NHS was depressingly long, until carefully differentiated. Top of the pile were items like the NHS’s asymmetric attitude to risk – successful innovations are forgotten, unsuccessful innovations are a life sentence for those involved – which are soluble only by those at the very top.
Then there were the surmountable challenges – for example the fear, uncertainty and doubt over digital health regulation was overcome by (more…)
A new app that can replace expensive, side effect-prone, drugs has been developed by Yorkshire tech company ADI (disclosure which manages the admin for this editor as Managing Director of DHACA, and provides one of DHACA’s three Directors), with assistance from Harrogate-based Inhealthcare. It is set to ease the burden on the NHS, alleviating daily chronic pain, initially available for some 7,000 patients it Leeds, making it one of the largest digital health services to be commissioned in the UK.
The app, called Painsense, will be free for patients to use. It gives them the knowledge, skills and guidance to manage their pain, which should reduce the need to visit their GP or hospital. It will be rolled out across other regions of the UK within the next six months.